Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study.
Rebecca C AllsoppQi GuoKaren PageShradha BhaganiAnna KasimPhilip BadmanLaura KennyJustin StebbingJacqueline A ShawPublished in: Breast cancer research and treatment (2024)
Changes in ctDNA can occur rapidly and reflect changes in patients' clinical tumour responses (NCT02681523).
Keyphrases
- metastatic breast cancer
- end stage renal disease
- circulating tumor
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- single molecule
- metabolic syndrome
- cell free
- patient reported outcomes
- locally advanced
- skeletal muscle
- bone marrow
- insulin resistance
- circulating tumor cells
- nucleic acid
- chemotherapy induced